Home/Filings/4/0001181431-10-040291
4//SEC Filing

Bassin David S 4

Accession 0001181431-10-040291

CIK 0001089473other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 4:31 PM ET

Size

18.8 KB

Accession

0001181431-10-040291

Insider Transaction Report

Form 4
Period: 2010-08-04
Bassin David S
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-08-041,3750 total
    Exercise: $8.45From: 2007-12-10Exp: 2013-12-10Common Stock (1,375 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-08-0411,2500 total
    Exercise: $17.25From: 2008-11-01Exp: 2014-11-01Common Stock (11,250 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-08-0466,5530 total
    Exercise: $10.82Exp: 2019-01-15Common Stock (66,553 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-08-0460,7190 total
    Exercise: $16.92Exp: 2017-01-04Common Stock (60,719 underlying)
  • Disposition to Issuer

    Common Stock

    2010-08-0453,6780 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-08-0410,9600 total
    Exercise: $35.01Exp: 2017-01-22Common Stock (10,960 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-08-0448,2740 total
    Exercise: $32.55Exp: 2018-01-18Common Stock (48,274 underlying)
Footnotes (8)
  • [F1]Includes 32,606 shares of unvested restricted stock that accelerated as a result of the merger transaction specified in note 2 below.
  • [F2]Disposed of in connection with the Agreement and Plan of Merger, dated May 6, 2010 (as amended), by and among inVentiv Group Holdings, Inc. (formerly Papillon Holdings, Inc.), inVentiv Acquisition, Inc. (formerly Papillon Acquisition, Inc.) and inVentiv Health, Inc. 40,272 shares were disposed of in exchange for cash consideration equal to $26.05 per share on the effective date of the merger. 13,406 shares were disposed of in exchange for shares of inVentiv Group Holdings, Inc. valuing the shares disposed of at $26.05 per share. These transactions are exempt under Rule 16b-3(e).
  • [F3]Date on which option became fully-vested and exercisable.
  • [F4]Option cancelled pursuant to the merger in exchange for cash consideration payable on the effective date of the merger equal to the difference between $26.05 and the exercise price of the option multiplied by the number of underlying shares. This transaction is exempt under Rule 16b-3(e).
  • [F5]Exercisable as to 8,220 shares as of 1/22/2010.
  • [F6]Option cancelled for no consideration.
  • [F7]Exercisable as to 24,138 shares as of 1/18/2010.
  • [F8]Option became fully-vested and exercisable at the effective time of the merger.

Issuer

INVENTIV HEALTH INC

CIK 0001089473

Entity typeother

Related Parties

1
  • filerCIK 0001399656

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:31 PM ET
Size
18.8 KB